You are using an unsupported browser. Please upgrade your browser to a newer version to get the best experience on CypComp Database.
Record Information
Version1.0
Creation Date2019-07-14 16:55:47 UTC
Last Updated2019-10-01 21:42:23 UTC
CypComp IDCC02548
Compound Information
NameEnzalutamide
Structure ImageWxcxuhsoupdcqv uhfffaoysa n
InChIKeyWXCXUHSOUPDCQV-UHFFFAOYSA-N
PubChem ID15951529
CypCompound Information
SetCypBoM Testing Set
Bonds of Metabolism (BoMs)
CYP1A2CYP2A6CYP2B6CYP2C8CYP2C9CYP2C19CYP2D6CYP2E1CYP3A4
  • Not Available
  • Not Available
  • Not Available
  • <32,10;Cleavage;R1>
  • <32,H;Oxidation;R1>
  • Not Available
  • Not Available
  • Not Available
  • Not Available
  • <32,10;Cleavage;R1>
  • <32,H;Oxidation;R1>
References
  1. Benoist GE, Hendriks RJ, Mulders PF, Gerritsen WR, Somford DM, Schalken JA, van Oort IM, Burger DM, van Erp NP: Pharmacokinetic Aspects of the Two Novel Oral Drugs Used for Metastatic Castration-Resistant Prostate Cancer: Abiraterone Acetate and Enzalutamide. Clin Pharmacokinet. 2016 Nov;55(11):1369-1380. doi: 10.1007/s40262-016-0403-6. [PubMed:27106175 ]
Download FileCC02548.sdf